Andreas Wildi
Partner
Dr. med. et lic. iur. HSG, Attorney at Law
Location
Contact
Direct phone: +41 58 658 29 15
andreas.wildi@walderwyss.com
Curriculum Vitae
"Andreas Wildi is extremely knowledgeable and responsive." - The Legal 500
"Andreas Wildi is an excellent lawyer. He is very agreeable to work with and very well connected." - Chambers and Partners
"Andreas Wildi has exceptional expertise, strategy, execution and service across all work areas." - Chambers and Partners
Andreas Wildi, born 1972, is a medical doctor and an attorney at law.
"Andreas Wildi is extremely knowledgeable and responsive." - The Legal 500
"Andreas Wildi is an excellent lawyer. He is very agreeable to work with and very well connected." - Chambers and Partners
"Andreas Wildi has exceptional expertise, strategy, execution and service across all work areas." - Chambers and Partners
He advises and represents companies, associations and NGOs in the life sciences and healthcare sector.
His main focus is on reimbursement and pricing as well as regulatory affairs relating to pharmaceuticals and medical devices.
Andreas Wildi studied medicine at the University of Zurich and received his doctorate (Dr. med. / MD). While working part-time as a doctor in a hospital, in international rescue services and assisting / substituting general practitioners, he completed his law studies at the University of St. Gallen HSG (lic. iur. HSG). Before being admitted to the bar, Andreas Wildi was a clerk at a Cantonal Court and a trainee in a recognized Zurich business law firm. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss Government, where he led the pharmaceutical reimbursement & pricing unit in the Federal Office of Public Health BAG. Andreas Wildi deepened his market access expertise internationally as EMEA market access law director for a large multinational life sciences company. Andreas Wildi has been a partner at Walder Wyss in Zurich and Berne since 2015.
Andreas Wildi works in German, English and French. He is admitted to the bar before all courts in Switzerland and is a guest lecturer in pharmaceutical law at the Law Faculty of the University of Lucerne and at the University of Bern’s KPM Center for Public Management.
Digital Healthcare 2026 – Trends & Developments
| by Andreas Wildi and Annemarie Lagger | in: "Chambers Global Practice Guides" | Online-PublikationDifferentiated EAE examination of Herbal Medicinal Products
| by Daria Lenherr-Segmüller, Thomas Gächter and Andreas Wildi | in: "jusletter" | ZeitschriftenSwiss pharmaceutical reimbursement and pricing: Ordinance Law Changes (KVV/KLV) as of January 2024: Today's Decision by the Swiss Federal Council (Bundesrat)
| by Andreas Wildi and Celine Weber | NewsletterThe Revised Law on Human Genetic Testing
| by Andreas Wildi, Lucina Herzog and Simon Mazidi | in: "Life Science Recht" | 31-38 | ZeitschriftenAccess to unapproved/non-listed drugs: A veritable maze
| by Carole-Anne Baud, Reto Baumann, Jean-Christophe Devaud, Valérie Junod and Andreas Wildi | in: "Aktuelle Juristische Praxis (AJP)" | 176-182 | ZeitschriftenEntry into force of the revised Swiss Medical Devices Ordinance and its implications for the medtech industry
| by Andreas Wildi and Monja Sieber | NewsletterThe Life Sciences Law Review Chapter 24 - Switzerland
| by Celine Weber and Andreas Wildi | in: "The Life Sciences Law Review - 9th Edition" | 377 - 389 | ZeitschriftenPharmaceutical Advertising – Switzerland
| by Andreas Wildi and Celine Weber | in: "Chambers Global Practice Guide" | ZeitschriftenTherapiewahlfreiheit vs. Wirtschaftlichkeitsgebot im Bereich der Spezialitätenliste
| by Andreas Wildi, Daniel Staffelbach and Stephanie Eggimann | NewsletterLiberté de choix de la thérapie vs principe du caractère économique dans le domaine de la liste des spécialités
| by Andreas Wildi, Daniel Staffelbach and Stephanie Eggimann | NewsletterUpdate: Postponement of EU Medical Device Regulation implementation due to COVID-19
| by Andreas Wildi and Monja Sieber | NewsletterThe Life Sciences Law Review Chapter 28 - Switzerland
| by Andreas Wildi and Celine Weber | in: "The Life Sciences Law Review - 8th Edition" | 412 - 525 | ZeitschriftenPostponement of EU Medical Device Regulation implementation due to COVID-19
| by Andreas Wildi and Monja Sieber | NewsletterHandbook on Foodstuffs and Utility Articles law
| by Annemarie Lagger, Andreas Wildi, Sophie Regenfuss, Celine Weber, Christine Leuch, Florian Roth, Hugh Reeves, Monja Sieber and Pandora Kunz-Notter | in: Daniel Donauer, Hugh Reeves und Celine Weber (Editor[s]) | Schulthess Verlag | Zürich | MonographienLife Science Law Update
| by Andreas Wildi, Celine Weber and Felix Tuchschmid | NewsletterLife Science Law Update
| by Andreas Wildi, Celine Weber and Felix Tuchschmid | NewsletterLife Science Law Update
| by Andreas Wildi, Celine Weber and Felix Tuchschmid | NewsletterLife Science Law Update
| by Andreas Wildi, Celine Weber and Felix Tuchschmid | NewsletterLife Science Law Update
| by Andreas Wildi, Celine Weber and Felix Tuchschmid | NewsletterThe Life Sciences Law Review Chapter 29 - Switzerland
| by Andreas Wildi and Celine Weber | in: "The Life Sciences Law Review - 7th Edition" | 405-416 | ZeitschriftenRecognitions
Other lawyers
-
Fabian Altmann
Senior Associate
Zurich -
Peter Bürkli
Counsel
Basel -
Stefano Codoni
Partner
Lugano -
Stephanie Eggimann
Managing Associate
Bern -
Markus R. Frick
Partner
Zurich -
Alexander Gutmans
Partner
Basel -
Lucina Herzog
Senior Associate
Zurich -
Michael Isler
Partner
Zurich -
Annemarie Lagger
Managing Associate
Zurich -
Mirjam Olah
Senior Associate
Zurich -
Daniel Staffelbach
Partner
Zurich -
Celine Weber
Managing Associate
Zurich -
Martin Zobl
Partner
Zurich